You gotta feel sorry for them . . . they only made a 175% profit on their stock options! If their 10Q had been ready earlier they could have sold sooner for a really huge profit (3 day waiting period on insider sales after 10Q). As it is they didn't waste a second dumping, did they?
Missed both earnings and revenue estimates (again!) so after hitting 52-week high on runup into earnings it only makes sense that this will return to teens . . . very soon!
Because what you're not considering - and this has been amply covered in various SA articles - is that the entire market for liver assay kits is very small. Check out Rick Pearson or Jason Napodano.
You could likewise ask the question if ONVO's product is so hot then why haven't they gotten one single solid collaborative agreement - ie- one with money involved?
'Further positive results were presented by Ro_che at the annual congress of the Amer_ican Assoc_iation of Can_cer Res_earch in Washington DC. '
'The 3D-micro tissues developed by In_Sphero build up human organs true to original in a miniaturized scale, enabling the improvement of predictability of in vitro tests analyzing new drug compounds.
Recently, the leading US pharma company Pfi_zer showed that the In_Sphero 3D-InSight liver tissues, which contain all important cell types of the human liver, delivered unmatched results in studies investigating the effects of liver toxic substances.'
Pfi_zer and Ro_che release positive study results with InSphero
Important key customers of In_Sphero AG, market leader in the area of three dimensional cell culture models for pharmaceutical research, presented the advantages of In_Sphero’s 3D-InSight-Micro tissues at international congresses.
Dude, Pfizer done come and gone . . . long gone!
Do a word search for 'Pfizer' in this year's 10-K. Nada.
Last year's 10-K? This-
In December, 2010 we entered into a Collaborative Research Agreement with Pfizer, Inc. (“Pfizer”) to develop tissue based drug discovery assays in two therapeutic areas utilizing our NovoGen MMX Bioprinter™ technology. We disclosed in 2012 that we had delivered constructs to Pfizer for internal evaluation as partial completion of the collaboration agreement; we additionally have delivered a study report to complete the scope of work in the original collaboration agreement. Constructs delivered by Organovo are currently being evaluated in the collaborator’s laboratory, and we anticipate that an additional agreement or agreements will be arrived at to utilize Organovo tissues in its future research efforts, although we can give no assurance that future agreements will be arrived at.'
Indeed. That was so two years ago!
Hey idiot what do you say about the fact that in early 2012 Pfizer paid Organovo $1M for a 'first-look' at their 3D liver assays, got them, looked real good we assume, and then were never heard from again? Yep, they didn't renew the contract, they didn't buy anything, they didn't invest anything, and the next thing you know they've become partners with Insphero who has been marketing a 3D liver assay all along?
There's plenty of revenues to be had if this thing weren't a pumped up piece of BS.
$69,000 says it all :-)
Sentiment: Strong Sell
SIXTY-NINE THOUSAND US DOLLARS!!!
That's stupendous and amazing!!! It proves that there really wasn't any reason for ONVO to hide all the details of their so-called 'collaborative agreements' and just give us a headline. Why they've been raking it in !!
Do you realize there's a lot of dry-cleaners who don't record that kind of revenue in three months??
Of course not many dry-cleaners have a market cap of $650,000,000 either ;-)
Not gonna be any doubters in Organovo come Monday, lol.
Sentiment: Strong Sell
This is one instance where more competition IS good for CBAK . . . CBAK's just about bankrupt and with this latest news there's a decent chance that at least now an LG could buy their assets in a forced sale situation. Obviously the common shareholders will still get squat (but some pretty stock certs which can be used to wallpaper the bathroom) but at least the institutions and big holders who lent CBAK money will get some pennies back on the dollar.
To valubyer- I and several others have written many complaints about the spammers which Yahoo has chosen to ignore. Yahoo has the ability to delete postings and accounts if they want to. Ergo they don't want to.
To live = evil, maybe they want more site traffic or maybe they're getting paid.
Anyway none of these shenanigans could keep this Hindenburg afloat. The way I figure it they haven't found any underwriter yet to help them monetize this latest iteration of the scam and they only have until May 14th before they have to post earnings again. Then the Lie gets exposed in black and white. So pump, pump, pump while the pumpin's good!
Just look at what two other popular pump and dumps - LIVE and PLUG - are doing . . . tanking.
So many bagholders got burned by the hype that now a silly press release like this morning has at best a half-day effect.
That's what happens when you have millions of shares that traded at far higher prices in the hands of bagholders.
For renting out their message board to pro spammers? I figure they lose a little money, inconsequential really, from driving away any customers who might have looked at banner ads so clearly LIVE must be paying them much more.
As of his last stock sale Andrew Gordon's ownership dropped to 3.4%.
(e) On April 9, 2014, the Reporting Person ceased to be the beneficial owner of more than 5% of the Issuer’s outstanding Common Stock
Andrew Gordon won't have to report stock sales anymore.
Their hedges are always long positions. You can look it up in the quarterly earnings reports. You can see what their average price is and easily deduce that they've gained an enormous amount.
You're ignoring the fact that Andrew only had $300,000 in stock sales last year and for that he has to sell $1,000,000 worth of stock last week?? That makes no sense at all. As for the fact that David didn't sell that's pretty cold comfort all things considered. There was no reason for Andrew to sell for that matter . . . unless there is a reason.
Sellers may have different reasons for selling but thinking that the stock is going to go higher isn't one of them. The Gordons used to have 2.4M shares between the two of them. Now they're down to about 500,000 which isn't just some 'diversification' plan. It's more like divestment plan. They've become rich raising over $20,000,000 liquidating their JVA holdings so the idea that they needed to raise even more money last week is specious.
Predictably the market has taken a dim view of Andrew's selling $1,000,000 worth of stock on Thurs and Fri in the high 7's and is now trading down to 7.38
Last year A. Gordon only sold $350,000 worth of stock (at 7.00 sh). At most his taxes would be about $120,000. He just sold a $1,000,000 worth of stock. He should be pretty well covered tax-wise I'd think. In fact he probably could have sold one-fifth of that if were just for taxes.